Listen to this article

The basics:

• Noom acquires Tailor Made Compounding to expand into preventive health, aging
• Kentucky-based pharmacy operates in 46 states with 400+ clinic partners
• Deal adds personalized therapies, compounding capabilities to Noom platform
• Move supports growth beyond weight loss into broader health care services

Digital heath platform Noom has purchased a compounding pharmacy as part of an effort to expand its lineup of behavior change programs.

The Princeton-based company announced the acquisition in an April 1 press release. Noom said adding Tailor Made Compounding will allow it to expand into the broader market of preventative health and aging.

Headquartered in Kentucky, 503A pharmacy TMC operates in 46 states across the U.S.

TMC provides both sterile and non-sterile compounding as well as a broad formulary spanning men’s and women’s health, weight management, healthy aging, supplements, cosmetics and IV therapy. The company boasts a customer base of more than 400 clinics and multiple telehealth partners.

TMC provides the scale and infrastructure to support a broad range of personalized therapies, Noom said. The company also noted the target’s state-of-the-art, 40,000-square-foot compounding facility.

TMC will operate as a wholly owned subsidiary under its current leadership. It will continue serving its full clinic base, too, Noom said.

According to the announcement, Noom expects to begin rolling out new areas of healthy aging later this summer.

‘It’s not the end point’

Noom launched in 2008. The company strives to empower individuals to live longer, healthier lives by connecting them to content, coaching, community and clinicians to improve whole-person health. The subscription-based app service includes programs for weight management, obesity care and diabetes prevention.

In a bid to meet surging consumer interest in weight-loss treatments, Noom also offers GLP-1 drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.

Over the past year, Noom has made several investments aimed at expanding beyond weight loss. That includes launching a free version of the Noom app as a healthy aging behavior companion.

Noom said acquiring TMC will broaden the therapies available to its users as well as support its continued expansion into treating conditions beyond weight loss.

“Weight health is the entry point to preventive care – and foundational to healthy aging,” shared Noom CEO Geoff Cook. “But it’s not the end point. This acquisition continues Noom’s expansion into healthy aging, supporting Noom’s mission to empower everyone, everywhere to live better longer – every day.”

He went on to say, “By pairing sustainable behavior change with prescription-grade catalysts, we make lasting change feel easy. TMC produces those catalysts. By bringing this capability in-house, we’re building the infrastructure to scale proactive care responsibly, grounded in quality, compliance, and long-term outcomes.”

TMC Chief Executive Officer Ross Jordan pointed to his company’s mission of delivering “the highest-quality therapies to support every individual’s health and wellbeing.”

He said, “By joining Noom, we can integrate those therapies into a proven behavior-change platform focused on long-term outcomes. With medicine and habit science working together, we can support a healthcare ecosystem built for individualized care and lasting outcomes.”